HOME >> BIOLOGY >> NEWS
New research suggests previously unrecognized mechanism by which blood vessels are patterned

(Philadelphia, PA) - Congenital heart disease (CHD) is a leading cause of mortality in children worldwide. According to the American Heart Association, Congenital cardiovascular defects are present in about one percent of live births and are the most common malformations in newborns. Researchers from the University of Pennsylvania School of Medicine have recently identified new signaling pathways that may lead to a better understanding of how this deadly disease forms. Jonathan Epstein, MD, Associate Professor of Medicine and the study's lead investigator, identified a receptor in endothelial cells (the cells that line blood vessels) that when interrupted in mice, results in CHD and defects in the growth and arrangement of blood vessels (patterning). "With the identification of this receptor, we hope to one day develop molecular medicines that will essentially steer developing blood vessels away from where they shouldn't go," said Epstein.

This finding - published in the July 2004 issue of Developmental Cell - may lay the groundwork for discovering ways to diagnose and prevent CHD. In an accompanying article in Developmental Cell, Epstein and collaborators at the National Institutes of Health demonstrated the pathways that they have discovered are functional in diverse organisms, including fish. In the larger picture, the researchers suggest this work may be crucial in determining why blood vessels migrate to certain destinations in the body.

The researchers engineered mice with an inactivated endothelial receptor, called PlexinD1. These mice had structural cardiovascular defects involving the outflow vessels of the heart, which resembled a common form of CHD in children and caused perinatal deaths of PlexinD1 deficient mice.

The type of CHD caused by inactivation of PlexinD1 in mice has previously been attributed to abnormalities of neural crest cells, which are important in setting up the correct arrangement of tissue in a developing embryo.
'"/>

Contact: Ed Federico
ed.federico@uphs.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
12-Jul-2004


Page: 1 2

Related biology news :

1. Leader in cancer treatment and prevention research honored
2. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
3. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
4. Belgian researchers explore revolutionary approach to angiogenesis
5. Award winning researchers reveal potential new role for Glivec
6. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
7. 16 APS exercise research highlights, from reduced flu mortality to proteomics & obesity
8. Gene chips research in cotton could lead to superior variety
9. Groundbreaking research could ignite new solutions to heat transfer in nano-devices
10. New hydrothermal vents discovered as South Pacific Odyssey research begins
11. University of Alberta researcher looks for clues to mysterious disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/4/2019)... ... April 02, 2019 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that it will host a roundtable ... National Harbor Hotel, Oxon Hill, Maryland, on April 10-12, 2019. , On Thursday, ...
(Date:4/4/2019)... ... April 03, 2019 , ... R3 Stem Cell ... its nationwide Centers of Excellence. R3 wants patients to feel secure when they ... protect patients from Centers that use inferior regenerative biologics, protocols or amounts, R3 ...
(Date:3/29/2019)... , ... March 28, 2019 , ... ... (PT) programme, a new PT programme entirely dedicated to Chinese biobanks was launched ... and Environmental Repositories (ISBER) and the Biobank Branch, China Medicinal Biotech Association (BBCMBA). ...
Breaking Biology News(10 mins):
(Date:4/8/2019)... FRANCISCO (PRWEB) , ... April 08, 2019 , ... ... accredited investors a $15 million preferred equity investment in the privately held pharmaceutical company, ... Its leading drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ...
(Date:3/27/2019)... ... , ... A leader in the field of Regenerative Veterinary Medicine, VetStem Biopharma ... and Canada since 2004. The primary indications for VetStem Regenerative Cell Therapy are ... cat, and horse. Recently, VetStem teamed up with the world-renowned San Diego Zoo ...
(Date:3/19/2019)... ... , ... The AACR annual conference pulls together a diverse group of clinical ... research. The Visikol team will be at the show at booth #3252 and will ... their digital pathology services . “For AACR this year we are highlighting specifically ...
(Date:3/19/2019)... ... March 19, 2019 , ... ... the largest hospital in Israel and the Middle East region, and Swiss-based ... state-of-the-art Cocoon™ manufacturing platform. The partnership will enable Sheba to vastly streamline ...
Breaking Biology Technology:
Cached News: